Showing 1341-1350 of 1587 results for "".
- New Approach Quantifies the Hydraulic Permeability of Skin, Revealing the Spongelike Properties of the Dermishttps://modernaesthetics.com/news/new-approach-quantifies-the-hydraulic-permeability-of-skin-revealing-the-spongelike-properties-of-the-dermis/2473480/A new approach to quantify the hydraulic permeability of skin reveals the spongelike properties of the dermis layer, according to a study in PNAS Nexus. For the study, Alan J. Grodz
- PDO Max Launches Molded Levo Max Threadshttps://modernaesthetics.com/news/pdo-max-launches-molded-levo-max-threads/2473472/PDO MAX is introducing Molded Levo Max, bi-directional and barbed threads that are engineered for contouring the lower face, jawline, and general submentum area. PDO Max's Molded Levo Max threads grab submental fat and reposition it along the natural contours created
- Nulastin Taps Felipe Jimenez, PhD, for Chief Science Officerhttps://modernaesthetics.com/news/nulastin-taps-felipe-jimenez-phd-for-chief-science-officer/2473462/Felipe Jimenez, PhD, is Nulastin’s new Chief Science Officer. Formerly of Benchmark Cosmetic Laboratories (a KDC/One company) and Guthy-Renker, Mr. Jimenez holds more than 30 patents on elastin regeneration. "This is a dream come true having F
- EWG Survey: Men’s Use of Personal Care Products Doubles Since 2004https://modernaesthetics.com/news/ewg-survey-mens-use-of-personal-care-products-doubles-since-2004/2473459/Men’s use of personal care products has doubled since 2004, according to new consumer survey commissioned by the Environmental Working Group. Specifically, the average adult man in the U.S. uses 11 different personal care products each day – nearly twice as ma
- Venus Concept Introduces Medical Advisory Board for AI.MEhttps://modernaesthetics.com/news/venus-concept-introduces-medical-advisory-board-for-aime/2473449/The primary mission of the medical advisory board will be to provide strategic input, guidance, and clinical recommendations regarding the Company's emerging robotic technology, AI.ME, which received its first 510(k) clearance from the U.S. Food and Drug Administration (FDA) in December 2022,
- ExoCoBio Completes Acquisition of Benevhttps://modernaesthetics.com/news/exocobio-completes-acquisition-of-benev/2473446/ExoCoBio has acquired a majority ownership in BENEV, a global medical aesthetic company that produces growth factor-based skincare products. ExoCoBio produces exosome-based regenerative aesthetics and medicine products and currently holds 54 patents and 15 scientifi
- Revealed: The Top Five Technology Trends Shaping the Beauty Industryhttps://modernaesthetics.com/news/revealed-the-top-five-technology-trends-shaping-the-beauty-industry-3/2473438/Generative AI technologies are increasingly transforming various industries, including beauty, according to a keynote presentation by Alice Chang, Founder and CEO of Perfect Corp at The Global Beauty and Fashion Tech Forum in New York City. “In today's fast-paced world, c
- It's Camp Time for Dermatologistshttps://modernaesthetics.com/news/its-camp-time-for-dermatologists/2473432/As kids across the country got ready for summer camp, dermatologists flocked to Brooklyn, NY, for their own version of summer camp: Neutrogena’s immersive SkinU Summer Camp. Instead of learning to swim, sliding down a zipline, or playing tennis like kids in camp oft
- Xeomin Performs Well in Phase 3 Studies of Upper Facial Lineshttps://modernaesthetics.com/news/xeomin-performs-well-in-phase-3-studies-of-upper-facial-lines/2473428/Two pivotal phase 3 clinical studies demonstrated the efficacy and safety of Xeomin (incobotulinumtoxinA) in the simultaneous treatment of horizontal forehead lines, glabellar frown lines, and lateral canthal lines, according to Merz Aesthetics. Merz Aesthetics will submit these data as
- IL-17 Linked to Skin Aging: Studyhttps://modernaesthetics.com/news/il-17-linked-to-skin-aging-study/2473426/Interleukin (IL)-17 may plays a central role in skin aging, according to research from Institute for Research in Biomedicine (IRB Barcelona) in collaboration with the National Center for Genomic Analysis (CNAG). The study, which was led by Dr. Guiomar Solanas, Dr. Salvador Azn